robust
consist
express
cell
surfac
marker
earli
well
differenti
myeloid
hematopoiet
cell
prompt
numer
investig
seek
defin
role
myeloid
cell
address
function
myeloid
directli
creat
null
mous
assess
respons
purifi
primari
macrophag
dc
wt
null
anim
cell
assay
inflammatori
diseas
model
implic
previous
find
mice
lack
develop
normal
normal
hematopoiet
profil
except
increas
thymic
peripher
cell
number
moreov
vitro
assay
appear
larg
dispens
aspect
phagocytosi
prolifer
antigen
present
test
although
observ
slight
decreas
actinindepend
erythrocyt
uptak
howev
agreement
publish
studi
show
lack
monocyt
complet
ablat
monocyt
adhes
wt
endotheli
cell
vivo
assess
four
inflammatori
diseas
model
show
lack
littl
effect
diseas
onset
progress
nomin
alter
gene
express
level
wt
null
macrophag
argu
compensatori
mechan
therefor
although
highli
express
myeloid
cell
reliabl
marker
myeloid
lineag
normal
leukem
cell
critic
regul
hematopoiet
develop
hemostasi
myeloid
cell
function
j
leukoc
biol
develop
technolog
readili
produc
mab
enabl
systemat
catalog
leukocyt
cell
surfac
molecul
prompt
first
leukocyt
type
workshop
subsequ
workshop
assign
leukocytebind
mab
group
term
cluster
differenti
cd
antigen
virtu
common
pattern
bind
panel
primari
hematopoiet
cell
cell
line
way
cell
surfac
molecul
defin
marker
cell
myeloid
lineag
normal
leukem
cell
subsequ
molecular
clone
cdna
show
ident
membraneteth
peptidas
apn
express
cell
addit
hematopoiet
system
epitheli
cell
renal
proxim
tubul
intestin
brush
border
cell
brain
fibroblast
activ
endotheli
cell
larg
type
ii
protein
short
cytoplasm
domain
hydrophob
transmembran
region
larg
extracellular
domain
contain
enzymat
activ
extracellular
peptidas
function
cleav
singl
neutral
amino
acid
n
terminu
small
peptid
therefor
substrat
function
vari
depend
tissu
express
exampl
brain
cleav
opioid
peptid
enkephalin
regul
neuron
signal
intestin
cleav
peptid
facilit
amino
acid
resorpt
persist
specif
myeloid
express
normal
cell
hematopoiet
lineag
prompt
numer
studi
implic
varieti
myeloid
cell
function
primarili
assay
correl
express
particular
function
inhibit
enzymat
activ
chemic
inhibitor
inhibitori
antibodi
activ
use
ligandmimick
crosslink
antibodi
address
function
directli
genet
creat
global
ko
test
anim
phenotyp
effect
number
myeloid
function
attribut
previous
myeloid
differenti
phagocytosi
antigen
present
inflammatori
process
find
express
dispens
hematopoiet
develop
physiolog
homeostasi
suggest
function
myeloid
cell
may
depend
specif
particular
immun
challeng
gener
crosslink
ligand
target
vector
construct
use
bac
sourc
murin
genom
dna
obtain
chori
bac
librari
construct
flox
construct
frtneofrt
region
use
recombin
method
assist
gttf
uchc
farmington
ct
usa
schemat
target
strategi
depict
see
fig
target
vector
electropor
murin
es
cell
line
mous
strain
neomycinresist
coloni
contain
target
construct
expand
transfer
pseudopregn
femal
result
chimer
mice
contain
target
allel
germlin
transmiss
target
allel
confirm
neo
cassett
excis
produc
mice
carri
flox
allel
final
flox
anim
mate
transgen
mice
express
cre
recombinas
ubiquit
hprt
gene
promot
cre
mnn
j
jackson
laboratori
bar
harbor
usa
produc
global
null
strain
global
ko
anim
backcross
subsequ
strain
experi
describ
report
perform
koko
control
mice
wtwt
backcross
least
six
gener
strain
jackson
laboratori
mice
hous
anim
facil
uchc
accord
institut
offic
laboratori
anim
welfar
guidelin
delet
assess
use
pcr
genotyp
mrna
express
analysi
rtpcr
immunohistochemistri
flow
cytometr
analysi
describ
wt
ko
allel
detect
primer
use
pcr
protocol
min
min
min
product
visual
electrophoret
separ
agaros
gel
primer
use
genotyp
label
see
bmdm
dc
isol
femur
tibia
medium
supplement
describ
previous
thioglycollateelicit
macrophag
harvest
flush
periton
caviti
untreat
resid
macrophag
thioglycollatetr
elicit
macrophag
h
mice
follow
red
cell
lysi
splenic
dc
singlecel
spleen
suspens
mice
posit
select
use
microbead
mac
column
separ
miltenyi
biotec
auburn
ca
usa
accord
manufactur
guidelin
murin
cell
isol
singlecel
splenocyt
suspens
use
neg
select
kit
deplet
nont
cell
accord
manufactur
protocol
miltenyi
biotec
murin
lung
endotheli
cell
anim
harvest
minc
treat
mgml
collagenas
roch
indianapoli
usa
digest
materi
serial
pass
needl
dnaseitr
worthington
biochem
corp
lakewood
nj
usa
endotheli
cell
posit
select
primari
rat
antimous
antibodi
mec
bd
bioscienc
san
jose
ca
usa
follow
sheep
antirat
igg
dynabead
use
magnet
separ
invitrogen
dynal
carlsbad
ca
usa
final
cellbead
pellet
resuspend
ml
complet
endotheli
cell
growth
medium
fb
lonza
walkersvil
walkersvil
md
usa
plate
fibronectinco
cellcultur
dish
medium
chang
h
cell
attach
bead
becam
visibl
h
plate
puriti
endotheli
cell
prepar
routin
vascular
endothelialcadherinposit
santa
cruz
biotechnolog
santa
cruz
ca
usa
upon
immunostain
total
rna
isol
cell
tissu
use
trizol
rtpcr
reaction
perform
use
superscript
ii
rt
kit
invitrogen
taq
polymeras
accord
manufactur
instruct
primer
set
use
amplif
exonspan
cdna
sequenc
follow
f
r
f
r
mgapdh
f
mgapdh
r
bm
cell
flush
femora
tibia
singlecel
suspens
obtain
repeat
pipet
stain
medium
mm
hepe
ph
singlecel
suspens
spleen
thymu
prepar
mechan
grind
tissu
frost
glass
slide
suspens
cell
wash
stain
media
erythrocyt
lyse
hypoton
shock
filter
cell
strainer
mm
nytex
sefar
kansa
citi
mo
usa
final
cell
count
hemocytomet
monitor
viabil
trypan
blue
dye
exclus
flow
cytometr
analysi
except
conjug
inhous
use
commerci
avail
conjug
antibodi
secondari
reagent
bd
pharmingen
san
diego
ca
usa
ebiosci
san
diego
ca
usa
analys
myeloid
marker
use
clone
coupl
allophycocyanin
clone
coupl
fluorescein
clone
coupl
pe
analys
cell
compart
use
clone
coupl
pe
clone
coupl
fluorescein
analys
b
cell
use
clone
coupl
fluorescein
analyz
dc
use
clone
coupl
allophycocyanin
analyz
express
use
biotinyl
clone
follow
second
step
streptavidin
coupl
pe
analys
cell
suspend
solut
stain
media
contain
gml
pi
dead
cell
stain
strongli
pi
gate
analysi
analys
done
facscalibur
flow
cytomet
becton
dickinson
san
jose
ca
usa
avail
institut
flow
cytometri
facil
uchc
ing
zeiss
axioplan
attach
zeiss
axiocam
highresolut
digit
camera
serum
ko
litterm
mice
incub
substrat
alapna
mgml
final
h
enzym
activ
determin
measur
absorb
result
free
pnitroanilin
nm
use
micropl
reader
captur
antibodi
serotec
uk
ad
ugml
bicarbon
buffer
flatbottom
maxisorp
plate
overnight
well
wash
pb
incub
step
block
ul
bsapb
h
room
temperatur
serum
sampl
ul
ad
h
biotinyl
mab
kind
gift
dr
william
paul
lab
immunolog
nih
bethesda
md
usa
ad
h
room
temperatur
follow
hrp
streptavidin
ugml
min
room
temperatur
trimethoxybenzo
acid
substrat
ul
ad
final
incub
room
temperatur
hcl
n
use
stop
reaction
plate
read
micropl
reader
nm
cytoselect
phagocytosi
assay
kit
use
accord
manufactur
instruct
cell
biolab
san
diego
ca
usa
bmdm
dc
elicit
resid
periton
macrophag
plate
confluenc
l
cultur
medium
plate
macrophag
plate
day
prior
assay
incub
overnight
co
dc
plate
h
prior
assay
cellswel
control
condit
treat
cytochalasin
block
phagocytosi
interact
actin
microfila
h
prior
assay
sheep
rbc
cappel
lab
cochranvil
pa
usa
opson
igg
direct
opson
nonopson
erythrocyt
l
ad
macrophag
dc
incub
h
nonphagocytos
erythrocyt
lyse
hypoton
buffer
extent
phagocytosi
determin
cell
wash
lyse
follow
addit
proprietari
erythrocyt
substrat
solut
absorb
measur
nm
bmdm
thioglycollateelicit
periton
macrophag
plate
cover
slip
cellsml
dmem
fb
cultur
overnight
stimul
gml
human
oxldl
suspens
respond
cell
whole
spleen
wt
ko
balbc
mice
cellenrich
spleen
popul
neg
select
use
pan
cell
isol
kit
miltenyi
biotec
respond
cell
mix
mitomycin
ctreat
stimul
cell
alexi
biochem
san
diego
ca
usa
incub
day
approxim
h
later
alamar
blue
dye
serotec
ad
mix
cultur
dilut
l
suspens
mix
thoroughli
prolifer
respond
cell
measur
day
later
detect
alamar
blue
fluoresc
excit
wavelength
nm
emiss
wavelength
nm
prolif
stimul
index
calcul
stimul
alon
divid
prolifer
count
respond
alon
isol
murin
lung
endotheli
cell
ml
seed
fibronectinco
gml
plate
grown
confluenc
h
endotheli
cell
basal
medium
cambrex
bio
scienc
walkersvil
md
usa
subsequ
monolay
untreat
basal
control
control
igg
mab
treat
gml
min
wash
extens
calceinlabel
elicit
macrophag
ad
adhes
allow
proceed
min
condit
assay
triplic
unbound
myeloid
cell
wash
away
extens
remain
cell
lyse
fluoresc
quantifi
cytofluor
persept
biosystem
framingham
usa
male
mice
week
old
inject
ip
ml
age
thioglycol
broth
pb
variou
timepoint
h
postinject
anim
kill
periton
caviti
lavag
use
ml
steril
pb
cell
collect
centrifug
wash
rbc
lyse
total
number
cell
count
type
ii
collagenspecif
antibodi
use
induc
arthriti
femal
mice
week
age
day
anim
inject
ip
lmous
arthrogencia
mab
cocktail
mg
total
chondrex
llc
seattl
wa
usa
pb
control
lp
l
g
pb
administ
ip
day
start
day
sever
arthriti
limb
score
everi
day
scale
normal
swell
andor
red
one
joint
swell
andor
red
one
joint
swell
andor
red
entir
paw
maxim
swell
mice
recov
lp
toxic
day
arthriti
progress
rapidli
diseas
peak
day
plateau
day
begin
week
age
wt
null
litterm
administ
dss
mp
biomed
irvin
ca
usa
dissolv
drink
water
day
control
group
mice
genotyp
receiv
drink
water
time
period
mice
weigh
assess
evid
gross
rectal
bleed
daili
basi
experi
spleen
weigh
termin
colon
formalinfix
swissrol
histolog
analysi
stain
h
e
percent
ulcer
tissu
along
entir
colon
calcul
analysi
perform
blind
manner
mice
treat
ul
croton
oil
sigma
chemic
co
st
loui
mo
usa
aceton
appli
outsid
one
ear
pinnea
altern
ear
treat
aceton
alon
twentyfour
hour
sensit
mice
kill
human
tissu
ear
harvest
use
biopsi
punch
obtain
equival
area
tissu
edg
pinna
ear
weight
record
sampl
fix
zinc
fix
invitrogen
overnight
paraffinembed
section
stain
h
e
serum
pair
agematch
male
femal
wt
null
anim
analyz
research
anim
clinic
patholog
facil
charl
river
laboratori
wilmington
usa
total
rna
isol
periton
two
individu
micegenotyp
four
sampl
bmdm
one
mous
genotyp
wt
null
mice
use
trizol
accord
manufactur
protocol
qualiti
control
rna
puriti
integr
evalu
denatur
gel
electrophoresi
od
ratio
analysi
agil
bioanalyz
agil
technolog
palo
alto
ca
usa
total
rna
amplifi
purifi
use
ambion
ilumina
rna
amplif
kit
ambion
austin
tx
usa
briefli
ng
total
rna
reversetranscrib
cdna
use
oligo
dt
primer
secondstrand
cdna
synthes
vitrotranscrib
label
label
crna
analyz
agil
bioanalyz
quantit
nanodrop
analysi
label
crna
hybrid
mous
beadchip
illumina
inc
san
diego
ca
usa
h
per
manufactur
instruct
beadchip
wash
stain
scan
illumina
beadarray
reader
microarray
data
extract
normal
analyz
use
illumina
genomestudio
softwar
illumina
v
express
beadchip
illumina
inc
contain
genespecif
oligonucleotid
probe
correspond
mous
transcript
variant
averag
redund
transcript
per
array
intens
data
normal
use
quantil
algorithm
genomestudio
differenti
express
gene
rel
respect
control
evalu
use
illumina
custom
error
model
calcul
p
valu
function
intens
differenti
biolog
technic
nonspecif
variat
sampl
p
valu
delet
rel
express
null
versu
wt
calcul
express
foldwt
express
data
rank
low
high
express
rel
wt
valu
gene
show
highest
differenti
express
list
supplement
tabl
dataset
analyz
use
ingenu
pathway
analysi
softwar
ingenu
system
redwood
ca
usa
condit
null
mice
produc
uchc
gttf
use
modif
recombin
method
describ
ref
gene
encod
exon
span
nearli
kb
chromosom
bac
contain
gene
identifi
blast
analysi
obtain
chori
bac
repositori
confirm
southern
blot
analysi
data
shown
repeat
attempt
target
region
gene
result
recombin
prompt
revis
strategi
depict
figur
loxp
recombin
site
insert
intron
exon
exposur
construct
cre
recombinas
would
result
gene
lack
exon
encod
enzymat
activ
site
put
ngrbind
site
major
extracellular
portion
molecul
addit
splice
exon
introduc
frameshift
result
stop
codon
earli
exon
would
predict
produc
protein
lack
exon
depict
fig
observ
rel
slight
modif
protein
sever
impair
traffick
cell
surfac
would
predict
larg
alter
induc
delet
would
similarli
affect
cell
surfac
express
inde
transfect
human
epitheli
cell
line
mutant
express
construct
lack
exon
show
cell
surfac
express
tag
fig
transfect
murin
es
cell
target
construct
result
five
founder
line
mix
background
one
expand
studi
germlin
transmiss
confirm
mice
cross
transgen
strain
express
cre
recombinas
control
ubiquit
hprt
promot
mix
background
creat
global
null
anim
homozyg
ko
healthi
fertil
overt
phenotyp
serolog
abnorm
data
shown
consist
independ
deriv
null
strain
delet
flox
region
locu
homozyg
null
anim
confirm
pcr
analysi
fig
evalu
mrna
protein
express
rtpcr
fig
immunohistochemistri
indic
complet
lack
express
kidney
small
intestin
fig
spleen
colon
liver
shown
tissu
null
anim
compar
abund
express
renal
proxim
tubul
brush
border
microvilli
wt
control
interestingli
function
assess
delet
standard
colorimetr
substrat
alapna
fig
left
ref
show
strike
retent
peptidas
activ
serum
null
anim
although
background
level
protein
present
sampl
assess
elisa
fig
right
suggest
commonli
use
method
assess
level
measur
peptidas
activ
well
result
use
assay
interpret
caution
role
hematopoiet
differenti
impli
pattern
express
variou
hematopoiet
lineag
normal
neoplast
hematopoiet
popul
express
specif
earliest
cell
commit
myeloid
lineag
cfugm
differenti
progeni
reliabl
diagnost
marker
certain
type
leukemia
recent
shown
highli
express
adult
pluripot
stem
cell
deriv
multipl
site
differenti
es
cell
well
subset
peripher
blood
progenitor
cell
addit
postul
play
role
fetal
liver
hematopoiesi
myeloid
cell
differenti
final
express
report
control
variou
hematopoiet
differenti
factor
howev
specif
contribut
normal
hematopoiesi
unknown
flow
cytometr
analysi
bm
spleen
thymic
cell
popul
show
indistinguish
distribut
cell
myeloid
b
cell
popul
wt
null
adult
anim
fig
except
signific
increas
number
thymic
popul
null
mice
seen
peripher
organ
modest
nonsignific
trend
toward
increas
cell
cell
bm
mice
furthermor
vitro
quantif
function
hematopoiet
progenitor
popul
hematopoiet
stem
cell
earli
lymphoid
progenitor
immatur
b
cell
spleen
bm
indic
differ
total
colonyform
abil
precursor
wt
versu
null
anim
data
shown
suggest
critic
regul
development
hematopoiesi
hemostasi
confirm
express
murin
cell
myeloid
lineag
delet
effici
cell
null
anim
isol
primari
bm
macrophag
thioglycollateelicit
periton
macrophag
bmderiv
dc
rtpcr
analysi
mrna
purifi
popul
control
kidney
tissu
indic
mrna
present
cell
isol
wt
null
anim
fig
flow
cytometr
analysi
protein
bmderiv
dc
confirm
express
cell
isol
wt
null
anim
fig
similar
examin
elicit
periton
macrophag
show
express
predominantli
popul
express
high
level
protein
fig
analysi
high
popul
macrophag
marker
wt
null
anim
show
ident
cytometr
profil
fig
argu
development
defect
result
lack
myeloid
cell
valid
use
popul
vitro
assay
implic
numer
myeloid
cell
function
wish
assess
function
null
cell
aspect
previou
report
shown
inhibit
diminish
prolif
capac
cell
vitro
vivo
investig
whether
lack
express
alter
cell
respons
test
abil
wt
null
cell
b
haplotyp
stimul
respond
foreign
mhc
molecul
express
cell
allogen
balbc
strain
haplotyp
mlr
measur
abil
apc
stimul
cell
respons
cell
activ
respons
antigen
mixtur
whole
splenocyt
purifi
cell
fig
left
right
respect
respond
cell
wt
ko
mice
mitomycin
parasit
protein
depict
domain
organ
buri
activ
site
red
circl
structur
truncat
protein
would
predict
result
delet
allel
right
c
antibodi
immunofluoresc
detect
human
cervic
carcinoma
cell
line
transient
express
truncat
left
exon
fulllength
right
human
cdna
cell
transfect
truncat
construct
show
antibodi
reactiv
pcr
detect
target
genom
locu
use
pcr
primer
shown
e
rtpcr
total
rna
harvest
indic
tissu
wt
heterozyg
het
null
anim
ko
primer
specif
cdna
control
gapdh
f
immunohistochem
detect
wt
ko
kidney
left
intestin
right
use
polyclon
antibodi
show
stain
cell
renal
proxim
tubul
brush
border
microvilli
arrow
g
serum
null
anim
retain
abil
cleav
colorimetr
alapna
substrat
left
although
contain
nomin
level
protein
elisa
assay
right
graph
repres
four
independ
experi
analog
result
bar
repres
mean
sd
four
replic
ctreat
allogen
balbc
stimul
splenocyt
show
signific
differ
prolifer
either
respond
popul
activ
stimulu
similarli
wt
ko
splenocyt
capabl
stimul
prolifer
balbc
respond
cell
suggest
normal
level
surfaceexpress
stimul
molecul
mhc
iii
null
apc
consist
intact
antigenpres
function
absenc
report
present
complex
monocyt
cell
surfac
act
function
accessori
molecul
facilit
phagocytosi
latter
studi
found
enhanc
phagocytosi
antibodymodifi
target
cell
prolong
downstream
signal
upon
engag
presenc
crosslink
mab
primari
monocyt
myeloid
cell
line
suggest
may
function
regul
receptor
address
contribut
process
isol
bm
macrophag
fig
left
resid
fig
right
elicit
shown
primari
periton
macrophag
wt
null
mice
assay
abil
phagocytos
iggopson
control
nonopson
sheep
rbc
block
phagocytosi
perturb
microfila
assembl
cytochalasin
illustr
basal
uptak
nonopson
rbc
occur
phagocyt
mechan
differ
observ
microfilamentdepend
phagocyt
uptak
opson
target
cell
myeloid
lineag
test
thu
appar
dispens
phagocytosi
macrophag
dc
howev
reproduc
reduct
actinindepend
basal
uptak
null
cell
appar
possibl
relev
studi
implic
lipid
uptak
metabol
propos
target
cholesterol
uptak
inhibitor
ezetimib
enterocyt
macrophag
address
potenti
role
actinindepend
endocyt
process
assess
scaveng
receptormedi
uptak
oxldl
report
unaffect
cytochalasin
treatment
although
untreat
cell
either
genotyp
show
lipid
uptak
shown
percentag
lipidcontain
null
bmdm
fig
left
periton
macrophag
fig
right
compar
seen
wt
cell
suggest
requir
phagocytosi
scaveng
receptormedi
endocytosi
demonstr
recent
new
function
adhes
molecul
mediat
monocyteendotheli
cell
interact
crosslink
ligandmimick
antibodi
viral
ligand
result
increas
cellcel
adhes
format
molecular
complex
contain
endotheli
monocyt
suggest
may
particip
aspect
monocyt
traffick
inflamm
address
role
adhes
molecul
purifi
primari
lung
microvascular
endotheli
cell
wt
anim
assess
abil
wt
null
bmdm
adher
wt
endotheli
monolay
untreat
treat
antibodi
control
igg
although
overal
adhes
null
cell
slightli
lower
wt
untreat
control
monolay
treatment
endotheli
monolay
crosslink
antibodi
significantli
increas
adhes
wt
null
macrophag
fig
consist
result
human
cell
implic
myeloid
adhes
molecul
gainoffunct
manner
role
adhes
molecul
mediat
interact
myeloid
endotheli
cell
suggest
may
requir
optim
inflammatori
respons
consist
notion
inhibit
report
lessen
sever
acut
coliti
murin
model
inflammatori
bowel
diseas
report
play
role
express
cell
howev
induct
coliti
wt
null
anim
show
differ
weight
loss
standard
measur
diseas
progress
fig
top
addit
spleen
weight
percent
colon
ulcer
genotyp
compar
fig
middl
bottom
argu
critic
role
model
similarli
express
report
increas
synovi
fluid
patient
rheumatoid
arthriti
process
involv
infiltr
inflammatori
cell
affect
region
second
report
found
synovi
level
correl
posit
number
infiltr
lymphocyt
arthriti
patient
assess
contribut
inflammatori
phase
arthriti
use
model
cocktail
four
anticollagen
antibodi
inject
produc
rapid
synchron
diseas
independ
mhc
haplotyp
assess
respons
null
anim
mhcindepend
caia
show
discern
differ
mean
clinic
score
wt
null
anim
inject
antibodi
panel
timepoint
test
fig
suggest
mediat
inflammatori
cell
infiltr
damag
synovium
laboratori
shown
previous
administr
mab
strongli
diminish
leukocyt
transmigr
mous
model
periton
investig
lack
result
fewer
inflammatori
cell
infiltr
peritoneum
vivo
treat
wt
null
mice
ip
inject
thioglycol
broth
quantifi
infiltr
cell
periton
lavag
h
posttreat
contrast
antibodi
treatment
found
signific
differ
cell
number
periton
exud
two
genotyp
three
timepoint
test
fig
similar
dichotomi
antibodi
treatment
null
anim
periton
describ
previous
cell
surfac
molecul
thought
result
agonist
rather
block
function
antibodi
final
strain
shown
abl
compens
lack
adhes
molecul
critic
monocyt
traffick
strain
backcross
null
anim
onto
fvb
background
gener
mice
fulli
capabl
support
cell
infiltr
peritoneum
fig
argu
strainspecif
compens
anim
lack
final
test
mice
fourth
model
inflamm
croton
oilinduc
atop
dermat
model
acut
inflamm
local
irrit
induc
applic
croton
oil
skin
one
ear
control
vehicl
model
histamin
releas
activ
resid
mast
cell
produc
measur
edema
inflammatori
cell
infiltr
comparison
wt
nulltreat
ear
show
equival
level
edema
measur
weight
fig
well
presenc
compar
number
phenotyp
identifi
neutrophil
genotyp
wherea
littl
extravas
observ
vehicletr
control
ear
data
shown
taken
togeth
data
suggest
perhap
activ
asyetunidentifi
ligand
necessari
observ
effect
inflammatori
traffick
particip
respons
specif
inflammatori
trigger
lack
phenotyp
chang
variou
myeloid
function
assay
may
result
compensatori
effect
upregul
express
molecul
particip
process
assess
mrna
express
level
relev
gene
wt
versu
null
myeloid
cell
probe
illumina
microarray
beadchip
cdna
prepar
thioglycollateelicit
periton
macrophag
wt
ko
anim
subsequ
analysi
express
data
transcript
probe
use
genomestudio
softwar
indic
overal
express
gene
assay
differ
less
twofold
null
bar
repres
mean
sem
n
whole
spleen
n
purifi
cell
b
phagocytosi
assess
phagocytosi
bmdm
left
periton
macrophag
right
wt
ko
anim
iggopson
sheep
rbc
opson
untreat
rbc
nonopson
ad
phagocyt
untreat
treat
cytochalasin
block
phagocytosi
opson
cyt
phagocytosi
detect
colorimetr
bar
repres
mean
sem
n
c
scaveng
receptormedi
phagocytosi
wt
null
bmdm
left
periton
macrophag
right
assess
abil
intern
human
oxldl
detect
oil
red
oro
stain
data
express
percent
sd
oil
red
contain
cell
independ
field
n
untreat
cell
oxldl
either
genotyp
show
oil
red
stain
shown
must
present
macrophag
adher
antibodyactiv
endotheli
cell
untreat
fluorescentlabel
primari
murin
wt
ko
periton
macrophag
mac
ad
monolay
wt
murin
lung
microvascular
cell
untreat
pretreat
igg
mab
adhes
assess
bar
indic
mean
sd
fluoresc
intens
n
independ
experi
wt
macrophag
fig
supplement
tabl
similarli
analysi
express
specif
gene
involv
pertin
function
pathway
use
ingenu
pathway
analysi
softwar
show
explicatori
induct
relev
myeloid
gene
peptidas
adhes
molecul
etc
data
shown
argu
upregul
compensatori
gene
suggest
mani
myeloid
function
larg
independ
express
human
earli
myeloidcommit
progenitor
cell
well
differenti
progeni
strongli
suggest
function
role
cell
surfac
molecul
myeloid
develop
function
although
numer
report
investig
function
use
inhibitor
block
activ
mab
direct
genet
evid
role
variou
myeloid
cell
function
avail
current
studi
describ
product
analysi
mous
strain
harbor
flox
allel
cross
ubiquit
express
hprtcre
transgen
delet
nearli
code
region
gene
includ
region
specifi
enzymat
activ
site
zinccoordin
region
null
mice
viabl
fertil
suggest
development
physiolog
defect
agreement
studi
describ
independ
deriv
null
strain
find
similar
human
mrna
protein
express
murin
periton
bmdm
bmderiv
dc
express
abrog
complet
null
anim
nevertheless
cell
appear
larg
normal
mani
aspect
myeloid
cell
develop
function
lack
overt
phenotyp
null
anim
could
result
number
reason
unrel
function
role
formal
possibl
could
function
reduc
level
anim
delet
allel
retain
promot
transcript
start
site
initi
codon
thu
could
produc
truncat
transcriptprotein
contain
first
three
exon
splice
remain
exon
result
frameshift
stop
codon
earli
exon
howev
find
undetect
mrna
level
use
primer
span
nondelet
region
nt
agre
vitro
data
show
express
construct
contain
truncat
cdna
exon
produc
detect
tag
protein
fig
probabl
result
instabl
truncat
mrna
incorrect
fold
truncat
molecul
similarli
immunohistochem
flow
cytometr
elisa
assay
confirm
protein
detect
cell
tissu
anim
residu
function
activ
detect
null
cell
illustr
wide
use
alapna
assay
detect
activ
specif
use
caution
second
develop
loss
delet
molecul
often
result
upregul
function
similar
molecul
compens
deficit
howev
microarray
analysi
periton
bmdm
show
strike
similar
express
level
among
gene
wt
null
cell
argu
compens
regard
enzymat
activ
wt
null
mice
administ
dss
dissolv
drink
water
water
alon
day
mous
weight
record
top
spleen
weigh
termin
middl
percent
ulcer
colon
tissu
bottom
determin
histolog
calcul
percent
ulcer
tissu
entir
colon
n
micegenotyp
b
wt
null
mice
immun
arthrogencia
mab
blend
pb
day
assess
diseas
sever
initi
day
describ
materi
method
marker
repres
mean
sem
clinic
score
five
animalsgenotyp
iti
substrat
cleavag
argument
redund
compel
numer
cell
surfac
peptidas
share
overlap
substrat
specif
regard
although
prefer
substrat
ntermin
neutral
amino
acid
also
cleav
charg
residu
albeit
less
effici
possibl
anoth
enzym
substitut
produc
necessari
cleavag
product
anoth
possibl
mani
publish
studi
implic
use
monocyt
cell
line
human
peripher
blood
monocyt
current
studi
use
primari
macrophag
dc
formal
possibl
play
distinct
role
monocyt
differenti
myeloid
cell
address
current
studi
final
shown
gene
contribut
background
strain
compens
lack
critic
adhes
molecul
inflammatori
respons
particularli
periton
may
relev
studi
experi
describ
perform
anim
background
gene
contribut
strain
previou
studi
effect
inflammatori
challeng
wt
null
mice
background
indistinguish
anim
lack
fvb
background
show
sever
impair
inflammatori
respons
howev
current
studi
found
appar
requir
leukocyt
infiltr
periton
model
two
independ
inbr
strain
argu
background
influenc
caveat
asid
find
null
anim
normal
hematopoiet
develop
myeloid
cell
function
suggest
requir
physiolog
homeostasi
although
studi
exhaust
focus
process
implic
previous
studi
use
inhibitor
antibodi
express
shown
correl
particular
function
would
particularli
relev
lossoffunct
analysi
exampl
although
treatment
anim
inhibitor
aprotinin
show
signific
decreas
diseas
sever
dss
model
inflammatori
bowel
diseas
weight
loss
percent
ulcer
spleen
weight
null
anim
indistinguish
wt
anim
similarli
numer
studi
implic
role
aspect
human
cell
biolog
report
express
peripher
cell
subset
activ
cell
gener
treatment
inhibitor
describ
diminish
cell
prolifer
via
increas
product
result
seem
odd
observ
signific
increas
number
cell
null
thymu
may
result
dispar
origin
peripher
vs
thymic
cell
studi
altern
possibl
lack
alter
tight
regul
thymocyt
select
prolifer
surviv
identif
specif
cell
subset
affect
determin
increas
cellintrins
result
stromal
effect
possibl
impact
thymocyt
traffick
necessari
determin
exact
mechan
respons
increas
thymic
cell
null
anim
final
although
focus
specif
cell
function
mlr
measur
abil
primarili
cell
recogn
prolifer
respons
foreign
histocompat
antigen
mhc
mhc
ii
present
allogen
apc
cultur
mean
assess
capac
cell
selfrecognit
well
level
context
mhc
costimulatori
molecul
import
regul
cell
interact
involv
normal
immun
respons
found
signific
differ
function
null
cell
use
respond
stimul
cell
suggest
critic
cell
prolifer
level
context
molecul
requir
alloantigen
present
stimul
cell
unaffect
null
cell
discrep
publish
inhibitor
studi
may
result
offtarget
effect
peptidas
antagonist
compensatori
mechan
observ
slight
signific
decreas
uptak
actinindepend
nonopson
rbc
null
macrophag
scaveng
receptormedi
intern
modifi
ldl
also
actinindepend
actinindepend
mechan
illustr
receptormedi
receptorindepend
endocytosi
appear
depend
particular
antigen
cell
type
other
implic
previous
intern
distinct
surfac
protein
variou
cell
type
exampl
endotheli
cell
demonstr
inhibit
impair
intern
bradykininbradykinin
receptor
complex
perturb
lipid
raft
organ
effect
inhibit
downstream
signal
transduct
filopodia
format
cell
invas
possibl
decreas
actinindepend
uptak
erythrocyt
modifi
lipid
suggest
particip
specif
mechan
macrophag
uptak
possibl
pursu
current
contrast
consequ
inhibit
studi
laboratori
other
describ
gainoffunct
effect
cell
treat
crosslink
antibodi
trigger
signal
cascad
presum
mimick
ligandreceptor
interact
one
function
investig
phagocytosi
monocyt
demonstr
present
phagocyt
vesicl
concomit
crosslink
surfac
molecul
enhanc
phagocytosi
prolong
signal
via
fcr
suggest
may
function
signal
regul
howev
see
differ
uptak
similarli
opson
target
presenc
absenc
may
indic
similar
ligandbind
signal
receptor
must
crosslink
first
induc
downstream
signal
transduct
cascad
altern
compar
phagocyt
capac
cell
without
could
point
fact
although
crosslink
may
trigger
process
complement
elicit
normal
final
possibl
may
import
phagocytosi
certain
type
opson
antigen
also
crosslink
ligand
would
engag
fcr
thu
intern
effici
identif
ligand
current
focu
laboratori
although
appear
dispens
mani
physiolog
function
myeloid
cell
clearli
necessari
monocyt
adher
classic
tnfactiv
endotheli
cell
find
may
relev
defect
angiogenesi
report
independ
deriv
global
ko
strain
clear
mani
patholog
set
woundheal
tumor
ischem
injuri
cytokin
produc
infiltr
inflammatori
cell
promot
robust
angiogenesi
monocyt
adhes
endothelium
site
injuri
prerequisit
inflammatori
cell
infiltr
thu
defect
adhes
would
logic
decreas
number
infiltr
cell
reduc
proangiogen
cytokin
level
impair
angiogenesi
although
publish
studi
address
monocyt
infiltr
specif
may
well
contribut
observ
phenotyp
defect
adhes
also
consist
lack
phenotyp
respons
rel
gener
inflammatori
challeng
test
studi
may
also
speak
contradictori
result
antibodytr
versu
null
mice
periton
model
logic
specif
inflammatori
challeng
may
elicit
uniqu
molecul
bind
crosslink
thu
wherea
immun
challeng
treatment
antibodi
may
mimic
ligand
would
produc
phenotyp
distinct
lossoffunct
model
inde
shown
crosslink
mab
multival
ligand
human
coronaviru
lead
signal
transductiondepend
gainoffunct
increas
monocyt
adhes
endothelium
possibl
viru
coopt
normal
host
respons
crosslink
ligand
gain
access
tissu
may
phenocopi
ligand
thu
role
myeloid
cell
await
identif
ligand
undoubtedli
facilit
avail
null
anim
work
support
public
health
servic
grant
nation
cancer
institut
author
express
deepest
appreci
kati
lamoth
member
center
vascular
biolog
especi
laboratori
dr
kevin
claffey
dr
timothi
hla
uchc
dr
dan
wu
yale
univers
addit
thank
staff
follow
uchc
facil
gttf
flow
cytometri
facil
research
histolog
core
facil
author
declar
conflict
